Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Patrick C. Hines, MD, PhD
Researcher Assistant Professor in the Department of Physiology
Wayne State University School of Medicine
3901 Beaubien Street
Pediatrics Critical Care, Medicine
Detroit, Michigan, United States
Patrick C. Hines, MD, PhD is an experienced pediatric critical care physician (general and cardiac) and a vascular biology research scientist. He is also the Founder and CEO of Functional Fluidics, a startup company developing clinical bioassays to measure blood function during simulated flow with microliters of whole blood. This technology is being adopted by pharmaceutical companies, clinicians, and research scientists to evaluate new therapies for red blood cell disorders such as sickle cell disease, coagulation disorders, and cancer. Dr. Hines was selected to the inaugural class of the Aspen Global Leadership Network’s Health Innovators Fellowship. He was the Chairman of the board of directors for the SNMA in the past. Areas of Interest: Role of beta-adrenergic stimulation in erythrocyte adhesion to the pulmonary vasculature; mechanisms of sickle erythrocyte adhesion
Representative Publications:
Central nervous system events in children with sickle cell disease presenting acutely with headache
Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion
+myBinderRelated Content
-
Jessica Heath Templet, PAJessica Heath Templet is a certified Phy...
-
Four Solutions for Sickle Cell Disease SupportWhen Precious Lee was a year old, she be...
-
Children’s Hospital of WisconsinThe Sickle Cell Research Program at Chil...
-
Children’s Healthcare of Atlanta Sickle Cell Disease ProgramChildren's Healthcare of Atlanta's Sickl...
-
A Comparison of an Individualized and Weight-Based Opioid Protocols for the Treatment of Vaso-Occlusive Episodes in ...Introduction: Vaso-occlusive episodes ar...
-
Matthew Karafin, MD, MSMatthew Karafin, MD, MS is the associate...
-
Gene-Edited ‘Supercells’ Make Progress In Fight Against Sickle Cell DiseaseDoctors are reporting the first evidence...
